First 100 Days: Navigating New Frontiers: Life Sciences in the Trump Era
Webinar | 02.25.25, 1:00 PM EST - 2:30 PM EST
Please join us for a post-Election webinar with the heads of our Government Affairs group who will address the myriad of areas in the Life Sciences industry that will likely be impacted by the new administration, including FDA, NIH, drug pricing, imports, and exports.
Our resident Government Affairs experts Aaron Cummings, former Chief of Staff to U.S. Senator Chuck Grassley (R-IA), Stephen Holland, former Senior Health Counsel to the House Committee on Energy & Commerce and Ranking Member Frank Pallone, Jr. (D-NJ), and Jim Flood, former counsel to Senator Charles E. Schumer (D-NY), will respond to rapid-fire questions posed by lawyers from Crowell’s Health Care, Intellectual Property, International Trade, Government Contracts, and Corporate Transactions practice groups. Through this industry-focused discussion, our team will help you begin to identify, understand, and navigate the impact of the new administration on your business.
For more information, please visit these areas: Health Care
Participants
Insights
Webinar | 12.10.25
In 2025, the U.S. Government’s policy statements and Executive Orders have had far-reaching impacts for government contractors and grant recipients. Although terminations, stop work orders, and de-scopes have affected private companies, non-profits, and universities doing business across multiple agencies, the U.S. Government’s policies relating to the U.S. Agency for International Development (USAID) has caused particular confusion and uncertainty relating to performance, compliance, and contractual procedure. Key questions have included the potential impacts of official and less formal communications from the U.S. Government, procedural issues arising from the move of certain functions to the U.S. Department of State, and the effect of various pending litigations. As businesses and organizations plan for 2026, the importance of preserving their rights and maximizing potential recovery opportunities remains paramount.
Webinar | 11.24.25
AI in the Workplace: EU Rules for When Humans and Bots Team Up

